We are excited to introduce our latest innovation, the SynIRgy system, a groundbreaking advancement in the preclinical imaging field that is set to revolutionize the way we visualize and study tumors.

The SynIRgy system combines bioluminescence, NIR-I, and NIR-II imaging to enable precise colocalization of tumors (bioluminescence) with the benefit of sharp, high-resolution imaging (NIR-II).

Discover SynIRgy

IR VIVO SynIRgy Schematic representation:

Key Features of SynIRgy:

1. Precise Colocalization: By combining bioluminescence with NIR-I and NIR-II imaging, SynIRgy enables more accurate localization and quantification.
2. High-Resolution Imaging: The use of NIR-II imaging provides sharp, high-resolution images, making it easier to identify and study even the smallest of tumors.
3. Deeper Tissue Penetration: The NIR-II is a more consistent complementary modality to bioluminescence, able to collect ballistic photons from deeper in the tissue than visible or NIR-I fluorescence.
4. Use of Validated Dyes: The combination with NIR-I allows the use of a larger list of already validated dyes in this range, before a possible transition to NIR-II, making it a flexible and adaptable system.
   

See below a comparison of our three IR Vivo systems:

The SynIRgy system is the perfect combination of the power of bioluminescence and the advantages of NIR-II , making it an indispensable tool for researchers and clinicians working in the preclinical field.

We invite you to discover the SynIRgy system and learn more about the benefits of this advancement in preclinical imaging.